A practical reference on Pentadecapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-02-09 and is reviewed periodically as new material appears.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | About 1419.5 Da | Calculated from the fifteen-residue sequence |
| Residue count | 15 amino acids | Single-letter sequence GEPPPGKPADDAGLV |
| Compound class | Synthetic peptide | Produced by solid-phase synthesis |
| Synonyms | BPC 157; pentadecapeptide BPC 157 | Naming varies across suppliers and papers |
| Appearance | White to off-white powder | Typical form of the lyophilized material |
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
=== Detection in biological fluids === Zopiclone may be measured in blood, plasma, or urine by chromatographic methods. Plasma concentrations are typically less than 100 μg/L during therapeutic use, but frequently exceed 100 μg/L in automotive vehicle operators arrested for impaired driving ability and may exceed 1000 μg/L in acutely poisoned patients. Post mortem blood concentrations are usually in a range of 400 to 3900 μg/L in victims of fatal acute overdose.
== External links == Picture of Margaret Oakley Dayhoff, c. 1980. Owned by her daughter Ruth E. Dayhoff, M.D. Made available by the National Library of Medicine. Profile and photographs of Margaret O. Dayhoff in Grandma got STEM project. Information submitted to the project by Margaret Dayhoff's son-in-law Vincent, husband of Ruth E. Dayhoff. Also contains biographical information about descendants. Baby Joseph and Vrundha M. Nair .2012 Woman Innovator in Bioinformatics: Dr. Margaret Oakley Dayhoff. Adv Bio Tech:12 (01) 32–34
== Scale replicas == As indicative of the iconic nature of the P-51, manufacturers within the hobby industry have created scale plastic model kits of the P-51 Mustang, with varying degrees of detail and skill levels. The aircraft have also been the subject of numerous scale flying replicas. Aside from the popular model aircraft, several kitplane manufacturers offer 1⁄2, 2⁄3, and 3⁄4-scale replicas capable of comfortably seating one (or even two) and offering high performance combined with more forgiving flight characteristics. Such aircraft include the Titan T-51 Mustang, W.A.R. P-51 Mustang, Linn Mini Mustang, Jurca Gnatsum, Thunder Mustang, Stewart S-51D Mustang, Loehle 5151 Mustang and ScaleWings SW51 Mustang.
=== Binding stoichiometry === Growth hormone binds to GHBP and GHR via an interactive region of helices 1 and 4 of GH. Two receptor molecules are pre-dimerized upon GH binding, so it always binds in a 1:2 ratio. Assays estimate that growth hormone and growth hormone binding protein form a natural complex at a 1:1 ratio for transport and preservation of the ligand through the bloodstream. However, some sources have shown that high physiological concentration of GHBP will result in a 1:2 ratio. When the cysteine amino acids in GHBP are mutated and the disulfide bridges are disrupted, the ability of the ligand to bind to the active site of the GHBP is significantly lessened.
All of the adsorption sites are equivalent, and each site can only accommodate one molecule. The surface is energetically homogeneous, and adsorbed molecules do not interact. There are no phase transitions. At the maximum adsorption, only a monolayer is formed. Adsorption only occurs on localized sites on the surface, not with other adsorbates. These four assumptions are seldom all true: there are always imperfections on the surface, adsorbed molecules are not necessarily inert, and the mechanism is clearly not the same for the first molecules to adsorb to a surface as for the last. The fourth condition is the most troublesome, as frequently more molecules will adsorb to the monolayer; this problem is addressed by the BET isotherm for relatively flat (non-microporous) surfaces. The Langmuir isotherm is nonetheless the first choice for most models of adsorption and has many applications in surface kinetics (usually called Langmuir–Hinshelwood kinetics) and thermodynamics. Langmuir suggested that adsorption takes place through this mechanism:
Sources: en.wikipedia.org
Narrated by David Malone, produced by Simone Pilkington, directed by Tim Tate, made by Granada Television 21 December The Whale That Swam to London, an Equinox Special; it featured Rodney Coates of Seiche Underwater Acoustics, of Holsworthy in Devon, the former Professor of Acoustical Oceanography from 1990-96 at the University of Birmingham. Narrated by Dilly Barlow, produced by Nick Curwin, directed by Toby Macdonald, made by Firefly Film and Television Productions.
=== Development of Therapeutic and Diagnostic Procedures === This program studies molecular mechanisms of diseases including reproductive disorders, diabetes, and autoimmune conditions. It uses molecular biology and animal models to develop diagnostic kits and therapeutic strategies.
=== Spurs === The Igatpuri-Vadhavan Expressway will be developed as a 90 km long spur of the Mumbai–Nagpur Expressway, to connect Igatpuri with Vadhavan Port, which will be among the world's 10 largest ports.
Microfibrillated cellulose (MFC) was discovered later, in the 1980s, by Turbak, Snyder and Sandberg at the ITT Rayonier labs in Shelton, Washington. This terminology was used to describe a gel-like material prepared by passing wood pulp through a Gaulin type milk homogenizer at high temperatures and high pressures followed by ejection impact against a hard surface. In later work, F. W. Herrick at ITT Rayonier Eastern Research Division (ERD) Lab in Whippany also published work on making a dry powder form of the gel. Rayonier, as a company, never pursued scale-up and gave free license to whoever wanted to pursue this new use for cellulose. Rather, Turbak et al. pursued 1) finding new uses for the MFC, including using as a thickener and binder in foods, cosmetics, paper formation, textiles, nonwovens, etc. and 2) evaluate swelling and other techniques for lowering the energy requirements for MFC production. The first MFC pilot production plant of MFC was established in 2010 by Innventia AB (Sweden).
Impure welfarists consider additional factors, such as ensuring that well-being is distributed equally among people. This modification aims to avoid situations in which some people have abundantly good lives at the expense of others who experience severe deprivation. Another topic concerns the relation between moral virtue and well-being. According to one view, already considered in ancient Greek philosophy, the two always accompany each other, meaning it is in everyone's self-interest to act virtuously. An alternative perspective denies this close connection, stating that, at least in some cases, a virtuous person has to compromise their own well-being for the greater good. Philosophers further explore the relation between well-being and death. One position questions the common-sense idea that death is generally bad for a person. It argues that since death marks the end of a person's existence, there is nothing that can benefit or harm the person anymore. Animal ethicists apply the concept of well-being to non-human animals, examining what animal well-being consists in and how it affects the moral obligations of humans toward non-human animals. Commonly discussed factors of animal well-being include adequate food, shelter, and social interaction, and the fulfillment of species-specific needs.
Sources: en.wikipedia.org
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.
The number is an internal laboratory designation from the research group that first described the fragment. It does not encode a molecular weight, a receptor target, or a measured biological effect, and it carries no meaning outside the naming history of the compound.
It contains fifteen amino acid residues and has a calculated mass of roughly 1419.5 daltons. That places it in the short-peptide range, well below the size of small proteins, which affects how it is synthesized, purified, and analyzed.
Low temperature slows the chemical reactions, such as oxidation and hydrolysis, that break down a peptide chain. Water and oxygen are the main drivers of degradation, so a cold and dry environment extends usable life. Actual shelf life depends on the batch, the salt form, and the container.